Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449149 · ClinicalTrials.gov registry record · NA
Proton Radiation for Chordomas and Chondrosarcomas
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01449149 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 54 participants.
The verdict
NCT01449149, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The objectives of this study are 1) To evaluate the feasibility and acute side effects of proton therapy for chordomas and chondrosarcomas and 2) To evaluate clinical outcomes and long term side effects of proton beam radiation for treatment of chordomas and chondrosarcomas.
Interventions
- RADIATION Proton Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-03 |
| Est. Completion | 2025-09-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01449149
The ClinicalTrials.gov registry entry for NCT01449149 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Therapy is the first listed.
NCT01449149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01449149 about?
NCT01449149 is a clinical study titled "Proton Radiation for Chordomas and Chondrosarcomas". The objectives of this study are 1) To evaluate the feasibility and acute side effects of proton therapy for chordomas and chondrosarcomas and 2) To evaluate clinical outcomes and long term side effects of proton beam radiation for treatment of chordomas and chondrosarcomas.
What is the current status of trial NCT01449149?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2010-03. Estimated completion is 2025-09-04.
What interventions are being tested in trial NCT01449149?
The interventions under investigation include: Proton Therapy (RADIATION).
Who is sponsoring clinical trial NCT01449149?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.